MEGHAN PROMNITZ: Open Payments
NPI 1699063495 · SARATOGA SPRINGS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 34 payments from 14 companies in 2025. Trend: 2023 $53 · 2024 $411 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Lundbeck LLC | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Alkermes, Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Novo Nordisk Inc | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: VRAYLAR, REXULTI, TRINTELLIX, CAPLYTA, ARISTADA, AUSTEDO XR, Wegovy, SPRAVATO.
Industry payments across NY — which companies pay providers there.
